loader
Please Wait
Applying Filters...

Australian Register of Therapeutic Goods list of Approved Drug Products containing pentyl N-[1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-methyloxolan-2-yl]-5-fluoro-2-oxopyrimidin-4-yl]carbamate. Original Data : Therapeutic Goods Administration Website

Menu
$ API Ref.Price (USD/KG) : 241Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 2Alphapharm Pty Ltd

02 1Dr Reddy's Laboratories (Australia) Pty Ltd

03 1Sandoz Pty Ltd

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

The Battery Show
Not Confirmed
arrow
arrow
The Battery Show
Not Confirmed

capecitabine

Brand Name : Capecitabine Alphapharm

Dosage Form : tablet

Dosage Strength : 500 mg

Packaging : 120

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

blank

02

The Battery Show
Not Confirmed
arrow
arrow
The Battery Show
Not Confirmed

capecitabine

Brand Name : Xelabine

Dosage Form : tablet

Dosage Strength : 500 mg

Packaging : 120

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

blank

03

The Battery Show
Not Confirmed
arrow
arrow
The Battery Show
Not Confirmed

capecitabine

Brand Name : Capecitabine Sandoz

Dosage Form : tablet

Dosage Strength : 500 mg

Packaging : 120

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

blank

04

Dr Reddy's Laboratories (Australia) Pty ...

Country
The Battery Show
Not Confirmed
arrow

Dr Reddy's Laboratories (Australia) Pty ...

Country
arrow
The Battery Show
Not Confirmed

capecitabine

Brand Name : Capecitabine-DRLA

Dosage Form : tablet

Dosage Strength : 500 mg

Packaging : 120

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

blank